Actionable news
All posts from Actionable news
Actionable news in MRK: MERCK & CO. Inc,

FDA requests new data on Merck's bezlotoxumab, action date pushed out to October 23

Merck (NYSE:MRK) reports that the FDA has requested new data and analyses from the pivotal trials (MODIFY 1 and MODIFY II) supporting its Biologics License Application (BLA) seeking approval of...